14-day Premium Trial Subscription Try For FreeGet Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PRQR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for ProQR Therapeutics N.V. stock price on Monday moving between $1.19 and $1.51
(Updated on Nov 27, 2023)


Sell candidate since Nov 27, 2023 PDF
The ProQR Therapeutics N.V. stock price fell by -8.78% on the last day (Monday, 27th Nov 2023) from $1.48 to $1.35. During the last trading day the stock fluctuated 27.43% from a day low at $1.19 to a day high of $1.51. The price has risen in 7 of the last 10 days but is still down by -0.74% for this period. Volume has increased on the last day by 525 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 611 thousand shares were bought and sold for approximately $824.85 thousand.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.18% during the next 3 months and, with a 90% probability hold a price between $0.91 and $1.27 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

PRQR Signals & Forecast

The ProQR Therapeutics N.V. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $1.44. On a fall, the stock will find some support from the long-term average at approximately $1.31. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, November 20, 2023, and so far it has fallen -10.60%. Further fall is indicated until a new bottom pivot has been found. ProQR Therapeutics N.V. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Get your hands on a piece of history – invest in multi-million dollar paintings from $10k with Masterworks.

Support, Risk & Stop-loss for ProQR Therapeutics N.V. stock

ProQR Therapeutics N.V. finds support from accumulated volume at $1.30 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.325 between high and low, or 27.43%. For the last week, the stock has had daily average volatility of 10.21%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PRQR) For The Upcoming Trading Day Of Tuesday 28th

For the upcoming trading day on Tuesday, 28th we expect ProQR Therapeutics N.V. to open at $1.35, and during the day (based on 14 day Average True Range), to move between $1.23 and $1.47, which gives a possible trading interval of +/-$0.118 (+/-8.77%) up or down from last closing price. If ProQR Therapeutics N.V. takes out the full calculated possible swing range there will be an estimated 17.54% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.30 (3.70%) than the resistance at $1.44 (6.67%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is ProQR Therapeutics N.V. stock A Buy?

ProQR Therapeutics N.V. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.767 Open Broker Account

Sell Candidate Downgraded

Predicted Opening Price for ProQR Therapeutics N.V. of Tuesday, November 28, 2023

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Fair opening price November 28, 2023 Current price
$1.35 $1.35 (Overvalued)

Remember To Visit Our YouTube Channel


Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.67 23.95 %
R2 1.55 14.75 %
R1 1.47 9.07 %
Current price: 1.35
Support S1 1.22 -9.32 %
S2 1.15 -15.00 %
S3 1.02 -24.20 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.54 14.07 %
R2 1.48 9.63 %
R1 1.44 6.67 %
Current price 1.35
Support S1 1.30 -3.70%
S2 1.25 -7.41%
S3 1.23 -8.89%
What is the symbol for ProQR Therapeutics N.V. Stock and on which exchange is it traded?
The symbol for ProQR Therapeutics N.V. is PRQR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ProQR Therapeutics N.V. Stock?
ProQR Therapeutics N.V. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy ProQR Therapeutics N.V. Stock?
ProQR Therapeutics N.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ProQR Therapeutics N.V. Stock.

What's the current price of ProQR Therapeutics N.V. Stock?
As of the end of day on the 2023-11-27, the price of an ProQR Therapeutics N.V. (PRQR) share was $1.35.

What is the 52-week high and low for ProQR Therapeutics N.V. Stock?
The 52-week high for ProQR Therapeutics N.V. Stock is $3.85 and the 52-week low is $1.11.

What is the market capitalization of ProQR Therapeutics N.V. Stock?
As of the 2023-11-27, the market capitalization of ProQR Therapeutics N.V. is 109.563M.

When is the next earnings date for ProQR Therapeutics N.V.?
The upcoming earnings date for ProQR Therapeutics N.V. is 2024-03-27 00:00:00.

Click to get the best stock tips daily for free!

About ProQR Therapeutics N.V.

ProQR Therapeutics N.V. ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in... PRQR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT